Cancers (Aug 2022)

Vena Cava Thrombus in Patients with Wilms Tumor

  • Clemens-Magnus Meier,
  • Rhoikos Furtwängler,
  • Dietrich von Schweinitz,
  • Raimund Stein,
  • Nils Welter,
  • Stefan Wagenpfeil,
  • Leo Kager,
  • Jens-Peter Schenk,
  • Christian Vokuhl,
  • Patrick Melchior,
  • Jörg Fuchs,
  • Norbert Graf

DOI
https://doi.org/10.3390/cancers14163924
Journal volume & issue
Vol. 14, no. 16
p. 3924

Abstract

Read online

(1) Background: Vena cava thrombus (VCT) is rare in Wilms tumor (WT) (4–10%). The aim of this study is to identify factors for an outcome to improve treatment for better survival. (2) Methods: 148/3015 patients with WT (aged p p = 0.002). (4) Conclusions: As a result of our study, two risk factors for poor outcomes in WT patients with VCT emerge: diffuse anaplasia and metastatic disease, especially those with non-CR after PC.

Keywords